TickrTrends TVTX fair value analysis

Travere Therapeutics (TVTX) to Present New FILSPARI Data at ASN Kidney Week 2026

gurufocus.com · 2026-10-02

On October 02, 2026, Travere Therapeutics Inc (NASDAQ: TVTX) announced it will present nine new studies, including five oral reports, at the American Society of

Read the full story at gurufocus.com →

Is TVTX undervalued? See TickrTrends' fair value analysis →